{"podcast":{"title":"Business News Today | 2 Min News | The Daily News Now!","slug":"business-finance-news-today-2-min-news-the-daily-news-now-7726192","podcast_index_feed_id":7726192,"rss_url":"https://feeds.fastcast.ai/the-daily-news-now-business.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/cover/a77b5c94-431e-4490-8653-1f676f1da586.png","author":"The Daily News Now!","episode_count":2000,"summary":"Hosted by Corey with the Story, Business News Today is your daily source for the latest headlines and stories shaping the world of business, finance, and the global economy. From market trends and corporate earnings to startups, entrepreneurship, technology, real estate, consumer trends, and economic policy, we bring you the business news that matters most—in just a few minutes. Whether you're an entrepreneur, investor, executive, business owner, or simply someone who wants to stay informed, Business News Today delivers clear, concise updates to help you understand the forces shaping the economy and the future of business. Business News Today — Business news, all in one place. Powered by AI.","last_synced_at":"2026-09-17T06:21:31.382927+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192"},"episode":{"title":"Eli Lilly’s Vaccine Bet for the Future","slug":"eli-lilly-s-vaccine-bet-for-the-future","published_at":"2026-06-06T19:52:35+00:00","page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/eli-lilly-s-vaccine-bet-for-the-future","show_page_url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192","url":"https://api.fastcast.ai/audio/0d6d2132-03a6-45b8-ab9c-feef1a6baba0.mp3","audio_url":"https://api.fastcast.ai/audio/0d6d2132-03a6-45b8-ab9c-feef1a6baba0.mp3","summary":"Eli Lilly just splashed three point eight billion on vaccine companies, quietly shifting gears from its cash-gushing GLP-1 drugs like Mounjaro and Zepbound. While investors fixate on those blockbuster earners, this move is a strategic long-term play to diversify into infectious disease territory — a smart hedge against patent expiration and revenue slowdowns. It’s not flashy now, but it’s a calculated step toward building a more resilient, future-proof pharmaceutical powerhouse. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/374eb1ddc06eaab0","meta_description":"Eli Lilly just splashed three point eight billion on vaccine companies, quietly shifting gears from its cash-gushing GLP-1 drugs like Mounjaro and Zepboun…","key_points":[],"chapters":[],"topics":[],"duration_seconds":98,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/eli-lilly-s-vaccine-bet-for-the-future/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/eli-lilly-s-vaccine-bet-for-the-future.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}